The Food and Drug Administration approved Mylan's Lidocaine Patch 5%, a generic version of Endo Pharmaceutical's Lidoderm.
A drug made by Pfizer for treating pain disorders doesn't affect men's reproductive functions, according to a new post-approval clinical study.
The Food and Drug Administration has approved Lupin Pharmaceuticals' generic version of a drug used to treat pain and seizure disorders.
The Food and Drug Administration has approved a new indication for a Pfizer drug.
The Food and Drug Administration has approved a drug made by GlaxoSmithKline and XenoPort for treating pain associated with shingles.
Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.
Generic drug maker Impax Labs is challenging the patent protection on a drug used to treat postherpetic neuralgia, the company said Thursday.
A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.
A Food and Drug Administration expert panel will review a drug made by NeurogesX as a potential treatment for pain associated with HIV.
Depomed has launched a new drug for treating shingles, the drug maker said Monday.
Drug makers GlaxoSmithKline and XenoPort are seeking expanded approval for their restless legs syndrome treatment.
The Food and Drug Administration has approved a treatment for shingles made by a subsidiary of generic drug maker Mylan.
Generic drug maker Hi-Tech Pharmacal has received Food and Drug Administration approval for its version of a drug used to treat neurological disorders, the company said Tuesday.
The Food and Drug Administration has approved a new usage for a drug used to...
A company that develops drugs for pain is hoping to get approval of one of...
XenaCare announced Wednesday that its over-the-counter pain reliever, Cobroxin, will be featured on a segment...
A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...